Yayınlar & Eserler

Yayın Ağı
Makaleler 43
Tümü (43)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (30)
ESCI (7)
Scopus (30)
TRDizin (13)
Diğer Yayınlar (4)

1. Impulsivity and aggression in patients with methamphetamine use disorder and opioid use disorder

KARABULUT S., ERDOĞAN A., Kuloğlu Z., DÜZGÜN M., KULAKSIZOĞLU B.
Journal of Substance Use , cilt.31, sa.1, ss.77-81, 2026 (SSCI, Scopus) identifier

2. Robotic-Assisted Lymphovenous Anastomosis: A Systematic Review of Surgical Outcomes

Morkuzu S., Ozmen B. B., Buyuker C., Ozturk A., Fidan E. A., Ozdemir M., et al.
Microsurgery , cilt.45, sa.8, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Bruxism and Sleep Disorders in Patients Diagnosed With Depressive Disorder and Anxiety Disorder Using Antidepressants

Avan G. N. P., ERDOĞAN A., CİNEMRE B., KULAKSIZOĞLU B., METİN Ö.
Journal of Oral Rehabilitation , cilt.52, sa.1, ss.57-63, 2025 (SCI-Expanded, Scopus) identifier identifier

4. Clinical factors associated with craving in patients with opioid use disorder receiving buprenorphine-naloxone maintenance therapy

ERDOĞAN A., KARABULUT S., Coşkun M. N., TOSUN O., TURAN ÖZTAŞ F. N., KARSAVURDAN F., et al.
Journal of Substance Use , 2025 (SSCI, Scopus) identifier

5. The impact of smartphone addiction and social media addiction on traffic safety

DÜZGÜN M., ERDOĞAN A., KARABULUT S., ŞAFAK E., Kuloğlu Z., Ongun H. İ., et al.
Journal of Public Health (Germany) , 2025 (ESCI, Scopus) identifier

6. Childhood Traumas, Attachment Styles and Related Clinical Factors in Opioid Use Disorder

Topcuoğlu M., Coşkun M. N., ERDOĞAN A., KULAKSIZOĞLU B.
Noropsikiyatri Arsivi , cilt.61, sa.4, ss.339-344, 2024 (SCI-Expanded, Scopus, TRDizin) identifier identifier

7. Comparative evaluation of craving, sleep quality, sexual function and quality of life in opioid use disorder patients in remission with buprenorphine/naloxone maintenance treatment

Türker Z. G., ERDOĞAN A., CİNEMRE B., METİN Ö., KULAKSIZOĞLU B.
Human Psychopharmacology , cilt.39, sa.6, 2024 (SCI-Expanded, Scopus) identifier identifier

8. Night eating syndrome, impulsivity, sleep disorder and craving in opioid use disorder patients in remission phase

Turkmen P. E., ERDOĞAN A., KULAKSIZOĞLU B.
Heroin Addiction and Related Clinical Problems , cilt.26, sa.1, 2024 (SSCI) identifier

9. CHILDHOOD TRAUMAS, LOVE ATTITUDES, RELATIONSHIP SATISFACTION, AND SEXUAL FUNCTIONS IN EUTHYMIC DEPRESSIVE DISORDER PATIENTS

Bingöl M. S., ERDOĞAN A., KULAKSIZOĞLU B.
Psychiatria Danubina , cilt.35, sa.4, ss.508-514, 2023 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier identifier

10. HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study

Dilbaz N., Kuloğlu M., Evren E. C., Paltun S. C., Bilici R., Noyan C. O., et al.
Substance Abuse: Research and Treatment , cilt.17, 2023 (ESCI, Scopus) identifier identifier identifier

11. Second to fourth digit ratio (2D:4D), impulsivity and aggression levels in patients with opiate use disorder and alcohol use disorder

ERDOĞAN A., Özge B., KOPAN M., Aktan Y., KULAKSIZOĞLU B.
Journal of Substance Use , cilt.28, sa.6, ss.899-903, 2023 (SSCI, Scopus) identifier

12. Comparison of naltrexone implant and oral buprenorphine-naloxone in the treatment of opiate use disorder.

ERDOĞAN A., TOPCUOĞLU M., COŞKUN M. N., CİNEMRE B., KULAKSIZOĞLU B., KULOĞLU M. M.
Human psychopharmacology , cilt.37, sa.2, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

13. Sociodemographic and clinical characteristics of patients admitted to an addiction center

ERDOĞAN A., Dilcen H. Y., CİNEMRE B., KULAKSIZOĞLU B., İNAN D., Kuloglu M. M.
JOURNAL OF SUBSTANCE USE , cilt.27, sa.3, ss.321-327, 2022 (SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

14. A Comparison of Buprenorphine/Naloxone and Extended-Release Naltrexone Treatments in Terms of Sleep Quality, Sexual Life, Eating Behavior, and Quality of Life in Patients with Opiate Use Disorder

BIDI T., ERDOĞAN A., CİNEMRE B., KULAKSIZOĞLU B.
ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS , 2022 (TRDizin)

15. Dermatosis due to Methamphetamine Use: A Case Report

TOPCUOĞLU M., ERDOĞAN A., KULAKSIZOĞLU B.
ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS , cilt.8, sa.2, ss.157-159, 2021 (ESCI, TRDizin) identifier

16. Follow-up of serum naltrexone levels after naltrexone implant in opioid use disorder

KULAKSIZOĞLU B., ERDOĞAN A., CİNEMRE B., TOPCUOĞLU M., COŞKUN M. N., Ozdemir M., et al.
Heroin Addiction and Related Clinical Problems , cilt.23, sa.3, ss.23-28, 2021 (SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

17. Dermatosis Due to Methamphetamine Use: A Case Report

TOPCUOĞLU M., ERDOĞAN A., KULAKSIZOĞLU B.
ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS , cilt.8, ss.157-159, 2021 (ESCI)

18. Tattooing and Its Relationship with Impulsivity in Substance Use Disorder Madde Kullanım Bozukluğunda Dövme Özellikleri ve Dövmenin Dürtüsellik ile İlişkisi

ERDOĞAN A., Kara H., KÖSE F., CİNEMRE B., KULAKSIZOĞLU B., Kuloğlu M. M.
Neuropsychiatric Investigation , cilt.59, sa.1, ss.1-7, 2021 (Scopus) identifier

19. Successful treatment with long-acting injectable aripiprazole monohydrate for two patients with dual diagnosis - substance use disorder and psychotic disorder

ERDOĞAN A., KULAKSIZOĞLU B., BİNGÖL M. S., CİNEMRE B., Kuloglu M. M.
Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.34, sa.1, ss.102-106, 2021 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier

20. Hyponatremia due to duloxetine use in an elderly woman patient

CİNEMRE B., ERDOĞAN A., KULAKSIZOĞLU B., BİNGÖL M. S.
ORTADOĞU TIP DERGİSİ , cilt.12, sa.2, ss.295-298, 2020 (TRDizin)

21. Madde Kullanım Bozukluğu Tedavisinde Bir Yıllık Tedavide Kalma Oranları: Geriye Dönük Bir Çalışma

KULAKSIZOĞLU B., BİNGÖL M. S., GÜLENGÖZ M., KULOĞLU M. M.
FIRAT TIP DERGİSİ , cilt.25, sa.1, ss.43-47, 2020 (TRDizin)

22. Personality, temperament traits and impulsivity levels in opiate use disorder patients with and without intravenous use İntravenöz kullanımı olan ve olmayan opiyat kullanım bozukluğu hastalarında kişilik, mizaç özellikleri ve dürtüsellik düzeyleri

ERDOĞAN A., CİNEMRE B., KULAKSIZOĞLU B., Kuloğlu M. M.
Yeni Symposium , cilt.58, sa.3, ss.2-6, 2020 (Scopus) identifier

23. Comparison of oral naltrexone and naltrexone implant treatment in alcohol use disorders Alkol kullanım bozukluğunda oral naltrekson ve naltrekson implant tedavisinin karşılaştırılması

CİNEMRE B., ERDOĞAN A., KULAKSIZOĞLU B., METİN Ö., Kuloglu M. M.
Anadolu Psikiyatri Dergisi , cilt.21, sa.5, ss.477-482, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

24. Changes in serum BDNF levels after treatment of panic disorder patients

KULAKSIZOĞLU S., KULAKSIZOĞLU B.
Annals of Medical Research , cilt.26, sa.7, ss.1157-1160, 2019 (Hakemli Dergi)

25. Comparison of Caregivers of Schizophrenia and Chronic Renal Failure Patients in Terms of Family Burden, Social Support and Psychological Well-Being

KULAKSIZOGLU B., CİNEMRE B.
Journal of Biosciences and Medicine , sa.7, ss.33-40, 2019 (Hakemli Dergi)

26. The use of naltrexone implants for the treatment of opioid addiction: a retrospective study

KULAKSIZOĞLU B., Kara H., ÖZÇELİK Ö., Kuloglu M.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.20, sa.2, ss.133-138, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

27. Comparison of Caregivers of Schizophrenia and Chronic Renal Failure Patients in Terms of Family Burden, Social Support and Psychological Well-Being

KULAKSIZOĞLU B., CİNEMRE B.
Journal of Biosciences and Medicines , cilt.7, sa.04, ss.33-40, 2019 (Hakemli Dergi) Creative Commons License Sürdürülebilir Kalkınma

28. Effects of Community Mental Health Centers on Oxidative Stress in Patients with Schizophrenia

KULAKSIZOĞLU B., KULAKSIZOĞLU S.
International Journal of Clinical Medicine , cilt.9, sa.05, ss.423-431, 2018 (Hakemli Dergi) Creative Commons License Sürdürülebilir Kalkınma

29. Thiol/Disulfide Homeostasis in Schizophrenic Patients

Kulaksizoglu B., KULAKSIZOĞLU S.
NEUROCHEMICAL JOURNAL , cilt.12, sa.1, ss.102-106, 2018 (SCI-Expanded) identifier

30. Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

KULAKSIZOĞLU B., Kara H., BODUR B., Kuloglu M.
NEUROPSYCHIATRIC DISEASE AND TREATMENT , cilt.14, ss.3033-3035, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

31. The Relation of Socio-Demographic and Clinical Factors to Depression and Anxiety Levels in Diabetic Patients

ADAKAN F. Y., VURAL R., ŞAHİNTÜRK Y., BOYLUBAY Ş. M., YILMAZ Ü., KULAKSIZOĞLU B., et al.
Konuralp Tıp Dergisi , cilt.9, sa.2, ss.19-28, 2017 (Hakemli Dergi) Creative Commons License Sürdürülebilir Kalkınma

32. Thiol-Disulfide Homeostasis in Patients with Panic Disorder

KULAKSIZOĞLU B., KULAKSIZOĞLU S.
International Journal of Clinical Medicine , cilt.8, sa.01, ss.34-41, 2017 (Hakemli Dergi) Creative Commons License

33. The Relationship between Metabolic Syndrome, BDNF, and Vitamin D in Patients with Schizophrenia

KULAKSIZOĞLU S., Kulaksizoglu B.
NEUROCHEMICAL JOURNAL , cilt.11, sa.1, ss.104-111, 2017 (SCI-Expanded, Scopus) identifier identifier

34. Correlation of Metabolic Syndrome with Serum BDNF, Vitamin B12 And Folate In Schizophrenic Patients

KULAKSIZOĞLU B., KULAKSIZOĞLU S.
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES , cilt.7, sa.6, ss.3142-3151, 2016 (ESCI, Scopus) identifier identifier

35. Correlation of Metabolic Syndrome with Serum BDNF, Vitamin B12 And Folate In Schizophrenic Patients

Kulaksizoglu B., Kulaksizoglu S.
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES , cilt.7, sa.6, ss.3142-3151, 2016 (ESCI, Scopus) identifier identifier

36. Measurement of methionine level with the LC-ESI -MS/MS method in schizophrenic patients

KULAKSIZOĞLU S., Kulaksizoglu B., Ellidag H., EREN E., YİLMAZ N., Baykal A.
Ukrainian Biochemical Journal , cilt.88, sa.5, ss.107-115, 2016 (Scopus) Creative Commons License identifier identifier

37. Increased ratios of homocysteine/vitamin B12, homocysteine/folate and methionine/vitamin B12 in schizophrenic patients

KULAKSIZOGLU B., KULAKSIZOGLU S., ELLIDAG H. Y., CİNEMRE B., Baykal A., YILMAZ N.
NEUROCHEMICAL JOURNAL , cilt.10, sa.2, ss.166-171, 2016 (SCI-Expanded, Scopus) identifier identifier

38. Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia

Kulaksizoglu B., KULAKSIZOĞLU S.
NEUROPSYCHIATRIC DISEASE AND TREATMENT , cilt.12, ss.1999-2005, 2016 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

39. Investigation of Narcotic Substance Use among Individuals Who were under Probation in The City of Antalya

KULAKSIZOĞLU B., KULAKSIZOĞLU S., ELLİDAG H. Y., YİLMAZ N., BOZKURT S.
The Bulletin of Legal Medicine , cilt.20, sa.1, ss.21-26, 2015 (TRDizin) Creative Commons License

40. The Role of Anxiety and Emotional Stress as a Risk Factor in Treatment-Resistant Hypertension

Greenage M., Kulaksizoglu B., Cilingiroglu M., Ali R.
CURRENT ATHEROSCLEROSIS REPORTS , cilt.13, sa.2, ss.129-131, 2011 (SCI-Expanded) identifier identifier

41. EVALUATION OF SELF-ESTEEM WITH INTERNALIZED STIGMATIZATION IN THE PATIENTS WITH MENTALLY ILLNESS

Keser I., Saygin N., Turkan S., Kulaksizoglu B., Buldukoglu K.
EUROPEAN PSYCHIATRY , cilt.26, 2011 (SCI-Expanded, SSCI, Scopus) identifier

42. Depression and Coronary Heart Disease

Khan F. M., Kulaksizoglu B., Cilingiroglu M.
CURRENT ATHEROSCLEROSIS REPORTS , cilt.12, sa.2, ss.105-109, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

43. Case report: Comorbid anorexia nervosa and schizophrenia in a male patient

Cinemre B., Kulaksizoglu B.
TURK PSIKIYATRI DERGISI , cilt.18, sa.1, ss.87-91, 2007 (SSCI) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Akdeniz Üniversitesi Hastanesi Psikiyatri Polikliniğine 2018’de Başvuran Hastaların Sosyodemografik Özellikleri, Aldıkları Tanıların ve Başvuru Nedenlerinin Araştırılması

KULAKSIZOĞLU B.
6th International Symposium on Academic Studies in Health and Sport Sciences, 13 - 15 Haziran 2019, (Özet Bildiri)

2. Şizofreni ve Kronik Böbrek Yetmezliği Hasta Yakınlarının Aile Yükü, Sosyal Destek ve Ruhsal İyilik Hali Açısından Karşılaştırılması

KULAKSIZOĞLU B., CİNEMRE B.
ERASMUS International Academic Research Symposium on Health Sciences, 05 Nisan 2019, (Tam Metin Bildiri)

3. Etkileşim Bağlamında Ağrı Kesici ve Psikotrop Birlikte Kullanımı

KULAKSIZOĞLU B.
I. ULUSAL PSİKO-ONKOLOJİ KONGRESİ, Türkiye, 14 - 16 Kasım 2018, (Tam Metin Bildiri)

4. AKDENİZ ÜNİVERSİTESİ MADDE BAĞIMLILIĞI TEDAVİ MERKEZİNE BAŞVURAN HASTALARIN SOSYODEMOGRAFİK, MADDE KULLANIM ÖZELLİKLERİ VE TEMİZ KALMA ORANLARI

KULAKSIZOĞLU B.
International Hippocrates Congress on Medical and Health Sciences, 1 - 03 Mart 2019, (Özet Bildiri)

5. EVALUATION OF SELF-ESTEEM WITH INTERNALIZED STIGMATIZATION IN THE PATIENTS WITH MENTALLY ILLNESS

KESER İ., SAYGIN N., TÜRKAN Ş., KULAKSIZOĞLU B., BULDUKOĞLU K.
19. EUROPEAN CONGRESS OF PSYCHIATRY, Viyana, Avusturya, 12 - 15 Mart 2011, cilt.26, ss.461, (Özet Bildiri) identifier
Metrikler

Yayın

50

Yayın (WoS)

32

Yayın (Scopus)

31

Atıf (WoS)

75

H-İndeks (WoS)

4

Atıf (Scopus)

105

H-İndeks (Scopus)

5

Atıf (Scholar)

4

H-İndeks (Scholar)

1

Proje

3

Tez Danışmanlığı

1

Açık Erişim

11
BM Sürdürülebilir Kalkınma Amaçları